An anti-obesity device that forms a physical barrier between food and part of the intestine has achieved reductions in blood sugar levels and weight loss, according to the developer, GI Dynamics. The company has started clinical trials of the EndoBarrier, which is targeted at obese patients with type 2 diabetes.

Full Story:
Boston Herald

Related Summaries